GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Pre-Tax Income

ABL Bio (XKRX:298380) Pre-Tax Income : ₩-38,952 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. ABL Bio's pretax income for the three months ended in Mar. 2024 was ₩-11,971 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-38,952 Mil. ABL Bio's pretax margin was -150.82%.

During the past 8 years, ABL Bio's highest Pretax Margin was 4.77%. The lowest was -104627.45%. And the median was -816.91%.


ABL Bio Pre-Tax Income Historical Data

The historical data trend for ABL Bio's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Pre-Tax Income Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial -37,004.63 -55,605.92 -43,557.94 3,208.63 -2,646.66

ABL Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,334.61 -10,358.34 -4,109.45 -12,513.49 -11,971.11

Competitive Comparison of ABL Bio's Pre-Tax Income

For the Biotechnology subindustry, ABL Bio's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Bio's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABL Bio's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where ABL Bio's Pre-Tax Income falls into.



ABL Bio Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

ABL Bio's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2627.837+0+-2150.649+1293.888+837.935
=-2,647

ABL Bio's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-14278.465+0+-9.603+475.295+1841.664
=-11,971

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-38,952 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ABL Bio  (XKRX:298380) Pre-Tax Income Explanation

ABL Bio's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-11971.109/7937.206
=-150.82%

During the past 8 years, ABL Bio's highest Pretax Margin was 4.77%. The lowest was -104627.45%. And the median was -816.91%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ABL Bio Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of ABL Bio's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Bio (XKRX:298380) Business Description

Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines